Senti Biosciences Holdings, Inc.

Senti Biosciences Holdings, Inc., the post-merger successor to Dynamics Special Purpose Corp. (Nasdaq: DYNS), filed an 8-K current report with the Securities and Exchange Commission on June 30, 2025. Dynamics Special Purpose Corp. was a blank-check company that completed its initial public offering in 2021, sponsored by Dynamics Sponsor LLC, and targeted the life sciences and biotechnology sector before closing its business combination with Senti Biosciences, a synthetic biology company developing programmable gene circuit medicines. The 8-K represents a continuing material event disclosure for the combined operating entity. Investors and analysts seeking complete filing history, merger timelines, and SPAC analytics for DYNS can sign up for full data access at SpacDesk.